Pacific Hospital Supply Co., Ltd (TPEX:4126)
Taiwan · Delayed Price · Currency is TWD 79.20
+0.10 (0.13%)
May 29, 2026, 1:30 PM CST
Pacific Hospital Supply Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,383 | 2,406 | 2,345 | 2,320 | 2,185 | 2,019 | |
Revenue Growth (YoY) | -0.12% | 2.59% | 1.08% | 6.19% | 8.23% | -7.05% |
Cost of Revenue | 1,666 | 1,667 | 1,598 | 1,580 | 1,597 | 1,495 |
Gross Profit | 716.8 | 738.89 | 746.84 | 739.75 | 587.97 | 523.42 |
Selling, General & Admin | 178.21 | 183.45 | 184.05 | 184.31 | 187.36 | 162.72 |
Research & Development | 81.49 | 82.09 | 73.02 | 57.42 | 46.12 | 47.3 |
Operating Expenses | 259.7 | 265.54 | 257.07 | 241.73 | 233.48 | 210.02 |
Operating Income | 457.1 | 473.35 | 489.77 | 498.01 | 354.5 | 313.4 |
Interest Expense | -5.98 | -5.95 | -6.55 | -5.73 | -7.03 | -8.61 |
Interest & Investment Income | 20.22 | 20.48 | 22.35 | 17.61 | 3.72 | 0.25 |
Currency Exchange Gain (Loss) | -21.42 | -21.42 | 35.86 | -1.65 | 37.05 | -38.51 |
Other Non Operating Income (Expenses) | -9.68 | 9.09 | 16.67 | 20.01 | 19.96 | 17.56 |
EBT Excluding Unusual Items | 440.24 | 475.55 | 558.1 | 528.26 | 408.19 | 284.09 |
Gain (Loss) on Sale of Assets | 0.97 | 0.97 | -1.29 | -2.77 | 5.29 | 149.93 |
Pretax Income | 441.22 | 476.52 | 556.82 | 525.49 | 413.48 | 434.03 |
Income Tax Expense | 86.6 | 93.65 | 108.97 | 104.7 | 82.08 | 47.61 |
Net Income | 354.62 | 382.87 | 447.85 | 420.79 | 331.4 | 386.42 |
Net Income to Common | 354.62 | 382.87 | 447.85 | 420.79 | 331.4 | 386.42 |
Net Income Growth | -25.01% | -14.51% | 6.43% | 26.97% | -14.24% | 17.55% |
Shares Outstanding (Basic) | 66 | 73 | 73 | 73 | 73 | 73 |
Shares Outstanding (Diluted) | 66 | 73 | 73 | 73 | 73 | 73 |
Shares Change (YoY) | -9.59% | 0.07% | -0.05% | 0.05% | 0.06% | -0.00% |
EPS (Basic) | 5.41 | 5.27 | 6.17 | 5.80 | 4.56 | 5.32 |
EPS (Diluted) | 5.37 | 5.24 | 6.13 | 5.76 | 4.54 | 5.29 |
EPS Growth | -16.95% | -14.52% | 6.42% | 26.87% | -14.18% | 17.56% |
Free Cash Flow | 474.61 | 467.83 | 464.13 | 625.83 | 400.96 | 288.34 |
Free Cash Flow Per Share | 7.19 | 6.40 | 6.36 | 8.56 | 5.49 | 3.95 |
Dividend Per Share | 4.500 | 4.500 | 5.000 | 4.800 | 4.200 | 4.500 |
Dividend Growth | -10.00% | -10.00% | 4.17% | 14.29% | -6.67% | 7.14% |
Gross Margin | 30.08% | 30.71% | 31.85% | 31.88% | 26.91% | 25.93% |
Operating Margin | 19.18% | 19.67% | 20.88% | 21.46% | 16.23% | 15.52% |
Profit Margin | 14.88% | 15.91% | 19.10% | 18.14% | 15.17% | 19.14% |
Free Cash Flow Margin | 19.92% | 19.45% | 19.79% | 26.97% | 18.35% | 14.28% |
EBITDA | 576.87 | 592.45 | 612.87 | 624.99 | 487.38 | 458.58 |
EBITDA Margin | 24.21% | 24.63% | 26.13% | 26.94% | 22.31% | 22.72% |
D&A For EBITDA | 119.78 | 119.1 | 123.1 | 126.98 | 132.89 | 145.18 |
EBIT | 457.1 | 473.35 | 489.77 | 498.01 | 354.5 | 313.4 |
EBIT Margin | 19.18% | 19.67% | 20.88% | 21.46% | 16.23% | 15.52% |
Effective Tax Rate | 19.63% | 19.65% | 19.57% | 19.92% | 19.85% | 10.97% |
Revenue as Reported | - | - | - | - | - | 2,019 |